SCHEMBL13069232

SCHEMBL13069232

CC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 7/20 0.80
PGR P06401 4/20 0.77
AR P10275 3/20 0.77
HSD17B10 Q99714 1/20 0.77
HIF1A Q16665 3/20 0.76
HRH1 P35367 1/20 0.76
LMNA P02545 3/20 0.72
FNTA P49354 1/20 0.64
FNTB P49356 1/20 0.64
SERPINA6 P08185 2/20 0.60
SHBG P04278 2/20 0.57
CYP3A4 P08684 3/20 0.54
USP2 O75604 1/20 0.54
ALDH1A1 P00352 1/20 0.53
MAPK1 P28482 1/20 0.53
CYP2C19 P33261 1/20 0.53
MEN1 O00255 1/20 0.53
ADORA3 P0DMS8 1/20 0.53
MAPT P10636 1/20 0.53
MAPK3 P27361 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3394713 1.00 NR3C1 (0.80) NR3C1PGRARHSD17B10HIF1A
SCHEMBL21231580 1.00 NR3C1 (0.80) NR3C1PGRARHSD17B10HIF1A
SCHEMBL3394719 1.00 NR3C1 (0.80) NR3C1PGRARHSD17B10HIF1A
SCHEMBL7616035 0.92 NR3C1 (0.80) NR3C1PGRARHSD17B10HIF1A
SCHEMBL3406859 0.92 NR3C1 (0.80) NR3C1PGRARHSD17B10HIF1A
SCHEMBL11814061 0.90 NR3C1 (0.77) NR3C1PGRARHSD17B10HIF1A
SCHEMBL11814068 0.90 NR3C1 (0.77) NR3C1PGRARHSD17B10HIF1A
SCHEMBL8735123 0.90 NR3C1 (0.87) NR3C1PGRARHSD17B10HIF1A
SCHEMBL8735124 0.90 NR3C1 (0.87) NR3C1PGRARHSD17B10HIF1A
Fludrocortisone SCHEMBL21297043 0.89 NR3C1 (0.96) NR3C1PGRARHSD17B10HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2246359-A1 Process for obtaining fluorometholone and intermediates therefor Crystal Pharma, S.L.U. (ES) 2010-11-03 EP disclosed
WO-2010122096-A1 PROCESS FOR OBTAINING FLUOROMETHOLONE AND INTERMEDIATES THEREFOR CRYSTAL PHARMA, S.L.U. (ES) 2010-10-28 WO disclosed